Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS approval · 2025-02-14
Clinical Trial Update: Margetuximab Expanded Access Program
Margetuximab has received marketing approval, advancing its expanded access program for HER2-positive breast cancer and other HER2-positive …